During the past decade, Ochsner Clinic Foundation conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 21 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ochsner Clinic Foundation" #1 sponsor was "Pfizer" with 5 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Human Genome Sciences Inc." with 3 trials sponsored and "NSABP Foundation Inc" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ochsner Clinic Foundation" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Ochsner Clinic Foundation" are "Breast Cancer" (5 trials), "Rheumatoid Arthritis" (4 trials), "Systemic Lupus Erythematosus" (3 trials), "Arthritis, Rheumatoid" (2 trials) and "Lupus Erythematosus, Systemic" (2 trials). Many other conditions were trialed in "Ochsner Clinic Foundation" in a lesser frequency.

Most popular intervention types in "Ochsner Clinic Foundation" are "Drug" (28 trials), "Biological" (7 trials), "Other" (3 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Belimumab 1 mg/kg" (3 trials), "Belimumab 10 mg/kg" (3 trials), "Belimumab 4 mg/kg" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ochsner Clinic Foundation" are 27 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Ochsner Clinic Foundation". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Ochsner Clinic Foundation, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ochsner Clinic Foundation, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".